Format

Send to

Choose Destination
Trends Neurosci. 2001 Dec;24(12):695-700.

Gene therapy against neurological insults: sparing neurons versus sparing function.

Author information

1
Dept of Biological Sciences, Stanford University, Stanford, CA 94305, USA. tedd1@stanford.edu

Abstract

Increasing knowledge of neuron death mediators has led to gene therapy techniques for neuroprotection. Overexpression of numerous genes enhances survival after necrotic or neurodegenerative damage. Nonetheless, although encouraging, little is accomplished if a neuron is spared from death, but not from dysfunction. This article reviews neuroprotection experiments that include some measure of function, and synthesizes basic principles relating to its maintenance. Variations in gene delivery systems, including virus-type and latency between damage onset and vector delivery, probably impact the therapeutic outcome. Additionally, functional sparing might depend on factors related to insult severity, neuron type involved or the step in the death cascade that is targeted.

PMID:
11718873
DOI:
10.1016/s0166-2236(00)01956-1
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center